Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases

Publication: EMBO Molecular Medicine
UBC Author(s): Brent Page (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 17574676
Publication Date: 2024